Peptides such as the GLP-1 used in T2D care, and melanocortin-4 receptor (MC4R)-specific agonists, prolactin-releasing peptide mimetics, neuropeptides, and apolipoprotein A-I have been shown to possess anti-obesity functions [104]. The gene discussed is MC4R; the disease is obesity due to melanocortin 4 receptor deficiency.